MRNA) was among the notable gainers on Wednesday after Oracle (NYSE:ORCL) Chairman Larry Ellison highlighted the AI's potential in the development of messenger RNA-based cancer vaccines.

Moderna stock skidded on reports Robert F. Kennedy Jr. is considering pulling funding for its bird flu vaccine. Is MRNA stock ...

CEO Larry Ellison’s claims that artificial intelligence (AI) could help develop messenger RNA-based (mRNA) vaccines to cure cancer. We’ve all heard such blusterous aspirational hype before ...

And you can make that vaccine, that mRNA vaccine robotically, again, using AI, in about 48 hours." Honestly, this doesn't really excite me because Larry is primarily a tech entrepreneur ...

Nevertheless, artificial intelligence (AI) developments may supercharge the mRNA vaccine industry. At least, that's what Oracle CEO Larry Ellison believes. Ellison mentioned using AI to help ...

Many of them fixated on remarks that billionaire Larry Ellison, founder and former ... could lead to the AI-facilitated production of mRNA vaccines against cancer, explaining, “once we gene ...